Multiple Sclerosis: Mechanisms and Immunotherapy
@article{BaecherAllan2018MultipleSM, title={Multiple Sclerosis: Mechanisms and Immunotherapy}, author={C. Baecher-Allan and Belinda J. Kaskow and H. Weiner}, journal={Neuron}, year={2018}, volume={97}, pages={742-768} }
Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act on a genetically susceptible host. It features three clinical stages: a pre-clinical stage detectable only by MRI; a relapsing-remitting (RRMS) stage characterized by episodes of neurologic dysfunction followed by resolution; and a progressive stage, which usually evolves from the relapsing stage. Advances in our understanding of the immune mechanisms that contribute to MS have led to more than ten FDA… CONTINUE READING
Figures, Tables, and Topics from this paper
194 Citations
Adoptive Transfer of Regulatory T Cells as a Promising Immunotherapy for the Treatment of Multiple Sclerosis
- Medicine
- Front. Neurosci.
- 2019
- 3
- PDF
Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
- Medicine
- CNS Drugs
- 2020
- 8
- Highly Influenced
Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring
- Medicine
- Frontiers in Immunology
- 2020
- PDF
Altered astrocytic function in experimental neuroinflammation and multiple sclerosis.
- Biology, Medicine
- Glia
- 2020
Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis
- Medicine
- Brain sciences
- 2020
- 3
- Highly Influenced
- PDF
Reduction in CD11c+ microglia promotes clinical progression in autoimmune demyelination
- Biology, Medicine
- 2020
- PDF
‘Prototypical’ proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting
- Medicine
- Expert opinion on therapeutic targets
- 2020
- 2
- Highly Influenced
References
SHOWING 1-10 OF 294 REFERENCES
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis
- Medicine
- Therapeutic advances in neurological disorders
- 2016
- 20
Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
- Medicine
- Brain : a journal of neurology
- 2017
- 152
- PDF
Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation
- Medicine
- PloS one
- 2015
- 13
- PDF
Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response1
- Biology, Medicine
- The Journal of Immunology
- 2006
- 147
- PDF
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets
- Medicine
- European Neurology
- 2015
- 47
Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis
- Medicine
- Nature Reviews Neurology
- 2014
- 5
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
- Biology, Medicine
- Annals of neurology
- 2000
- 2,895
- PDF
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
- Medicine
- EBioMedicine
- 2017
- 122